Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Editas Medicine Upgraded at Evercore on CRISPR Platform
Vertex Pharmaceuticals Analyst Ratings
RBC Capital Reiterates Sector Perform on CRISPR Therapeutics, Maintains $53 Price Target
RBC Capital Maintains Sector Perform on Apellis Pharmaceuticals, Lowers Price Target to $24
Beam Stock Rebounds as Leerink Upgrades Despite Fatality in Gene Editing Trial
A Glimpse of Intellia Therapeutics's Earnings Potential